Perrigo Company News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.01.18	Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream (PR Newswire)
24.01.18	Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo® Gel (PR Newswire)
08.01.18	Perrigo Appoints Gerresheimer's Former CEO Uwe Röhrhoff As President, CEO (RTTNews)
08.01.18	Perrigo Appoints Uwe Röhrhoff As President & Chief Executive Officer (PR Newswire)
03.01.18	Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07% (PR Newswire)
27.11.17	Perrigo Announces the Launch of an AB Rated Generic Version of Mycolog® II Cream (PR Newswire)
27.11.17	Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo® 32mg Extended Release Tablets (PR Newswire)
21.11.17	Perrigo Company Completes Divestiture Of API Business For $110 Million (PR Newswire)
10.11.17	Perrigo Company to Present at the Stifel 2017 Healthcare Conference (PR Newswire)
09.11.17	Perrigo Co. Earnings Advance 12% In Q3 (RTTNews)
09.11.17	Perrigo Posts Profit In Q3; Lifts FY Adj. EPS View - Quick Facts (RTTNews)
09.11.17	Perrigo Company plc Reports Third Quarter 2017 Financial Results (PR Newswire)
02.11.17	Perrigo Company plc Announces Quarterly Dividend (PR Newswire)
02.11.17	Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato® Gel 0.05% (PR Newswire)
26.10.17	Perrigo To Release Third Quarter 2017 Financial Results On November 9, 2017 (PR Newswire)
24.10.17	Perrigo Announces Tentative FDA Approval For A First-To-File Generic Version Of Picato® Gel .015% (PR Newswire)
27.09.17	Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules (PR Newswire)
21.09.17	Perrigo:FDA Oks AB Rated Generic Version Of Exalgo 32mg Extended Release Tablets (RTTNews)
21.09.17	Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets (PR Newswire)
18.09.17	Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel (PR Newswire)
30.08.17	Perrigo Company To Present At Upcoming Investor Conferences (PR Newswire)
21.08.17	Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules (PR Newswire)
16.08.17	Perrigo: FDA Approves AB Rated Generic Version Of Mycolog II Cream (RTTNews)
16.08.17	Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream (PR Newswire)
11.08.17	"FCA Replay" Wraps the Week (PR Newswire)
11.08.17	ACHV Soars On New Achievement, AEZS Shrinks Q2 Loss, TXMD On Watch (RTTNews)
10.08.17	MÄRKTE USA/Nordkorea-Konflikt drückt Aktien massiv abwärts (Dow Jones)
10.08.17	SK Capital To Buy Perrigo's Active Pharma Ingredients Business (RTTNews)
10.08.17	Perrigo Q2 Loss Narrows; Raises Full-year Adj. Earnings Outlook - Quick Facts (RTTNews)
10.08.17	Perrigo Company plc Reports Second Quarter 2017 Financial Results (PR Newswire)
08.08.17	Perrigo Company plc Announces Quarterly Dividend (PR Newswire)
07.08.17	AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch (RTTNews)
04.08.17	Perrigo Announces Tentative FDA Approval For Generic Version Of Mirvaso® Gel (PR Newswire)
01.08.17	Today's Research Report Coverage on Healthcare Stocks -- Perrigo, Immune Pharma, Tonix Pharma, and United Therapeutics (PR Newswire)
31.07.17	Perrigo Announces The Launch Of The AB Rated Generic Version Of Transderm Scop® 1.5 mg (PR Newswire)
27.07.17	Perrigo To Release Second Quarter 2017 Financial Results On August 10, 2017 (PR Newswire)
19.07.17	Perrigo : FDA Oks AB Rated Generic Version Of DermOtic Oil, 0.01% Ear Drops (RTTNews)
19.07.17	Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of DermOtic® Oil, 0.01% Ear Drops (PR Newswire)
17.07.17	Perrigo Confirms Patent Challenge For Generic Version Of Soolantra® Cream, 1% (PR Newswire)
17.07.17	Perrigo Announces FDA Final Approval For Its First-To-File Ab Rated Generic Version Of Androgel® Topical Gel, 1.62% Packets (PR Newswire)
17.07.17	Perrigo Announces Settlement Of Generic Version Of Dymista® Nasal Spray Patent Litigation (PR Newswire)
05.07.17	Perrigo Launches The Generic Version Of Axiron® Topical Solution (PR Newswire)
21.06.17	Perrigo Company Retains Spencer Stuart for CEO Search (PR Newswire)
21.06.17	Perrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS® Scalp Oil and Body Oil (PR Newswire)
21.06.17	Healthcare Stock Performance Review -- Perrigo, LifePoint Health, Select Medical, and Universal Health Services (PR Newswire)
19.06.17	Perrigo Announces the Launch of Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution (PR Newswire)
14.06.17	Perrigo Company plc Announces Pricing for its Cash Tender Offer (PR Newswire)
14.06.17	Perrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference (PR Newswire)
14.06.17	Perrigo Company plc Announces Early Tender Results for Cash Tender Offer (PR Newswire)
06.06.17	Perrigo CEO John Hendrickson To Retire (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.10.24		S&P 500 aktuell: S&P 500 gibt nach
30.09.24		Handel in New York: S&P 500 fällt nachmittags
09.08.24		Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge
09.08.24		Gewinne in New York: S&P 500-Börsianer greifen zu
09.08.24		Verluste in New York: S&P 500 fällt am Mittag zurück
06.08.24		Pluszeichen in New York: S&P 500 mittags fester
05.08.24		Handel in New York: S&P 500 verbucht schlussendlich Verluste
11.06.24		Pluszeichen in New York: S&P 500 legt schlussendlich zu

21.10.24

S&P 500 aktuell: S&P 500 gibt nach

30.09.24

Handel in New York: S&P 500 fällt nachmittags

09.08.24

Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge

09.08.24

Gewinne in New York: S&P 500-Börsianer greifen zu

09.08.24

Verluste in New York: S&P 500 fällt am Mittag zurück

06.08.24

Pluszeichen in New York: S&P 500 mittags fester